Archives
-
CX-5461 and RNA Polymerase I in Cancer Research
2026-10-08
CX-5461 is a research compound used to examine RNA polymerase I, ribosome biogenesis stress, DNA damage, mitotic catastrophe, autophagy, and cellular senescence in cancer models. Published cervical cancer findings support further preclinical investigation, but the available evidence remains model-dependent and does not establish clinical efficacy or a universally Pol I-specific mechanism.
-
LNP Surface Charge and V-ATPase Drive Delivery
2026-10-08
Yang et al. propose that lipid nanoparticle tropism is shaped jointly by LNP surface charge and the V-ATPase state of recipient cells, rather than by nanoparticle properties alone. Their in vitro and in vivo findings connect charge-dependent delivery with endo/lysosomal function, providing a mechanistic framework for interpreting liver and lung targeting while highlighting important limits to generalization.
-
TECPR1 Repairs Lysosomes During Energy Crisis
2026-10-07
A 2026 Cell Research study identifies TECPR1 as a mediator of lysosomal membrane repair during glucose starvation and lysosomal membrane permeabilization. The work links PI4P-dependent TECPR1 recruitment to KIF1A-associated membrane tubulation, while cellular, reconstituted, and mouse-model evidence connects this pathway to metabolic stress adaptation.
-
L. gasseri, NR1I3, and E-Cadherin in Colitis
2026-10-07
Qian et al. report that Lactobacillus gasseri ATCC33323 reduces DSS-induced colitis in mice through an intestinal barrier mechanism involving NR1I3, CDH1 transcription, and E-cadherin. The study is notable because it combines probiotic treatment, intestinal E-cadherin perturbation, transcriptional analysis, and in vitro validation, while remaining limited by its preclinical model and need for confirmation in human IBD.
-
ZCL278 and the Translational Case for Cdc42
2026-10-06
Cdc42 sits at the intersection of cytoskeletal organization, trafficking, migration, and fibrosis. This thought-leadership analysis examines ZCL278 as a selective Cdc42 inhibitor, places supplier-reported cellular findings alongside recent kidney-fibrosis research, and defines the evidence needed to move from pathway modulation to translational confidence.
-
Bay 11-7821 in NF-κB and Sepsis Research
2026-10-06
A source-grounded overview of Bay 11-7821, also called BAY 11-7082, covering its reported NF-κB-related activities, conceptual relevance to lactate–HMGB1 signaling in sepsis, cancer and apoptosis research, and the limits of current evidence.
-
Azithromycin and Roxithromycin as Senolytics
2026-10-05
Ozsvari and colleagues identified azithromycin and roxithromycin as selectively active against DNA-damage-induced senescent human fibroblasts, while the related antibiotic erythromycin lacked comparable activity. The study combines a fibroblast screening model with protein-content, real-time impedance, and metabolic measurements, providing an important in vitro starting point for senolytic drug repurposing rather than clinical evidence of anti-aging efficacy.
-
ABT-263 and Senolytic Research in Melanoma
2026-10-05
ABT-263, also known as Navitoclax, is a BCL-2 family inhibitor used in apoptosis and senescence research. Evidence supplied here supports a context-dependent role for BCL-2/BCL-XL inhibition in eliminating some therapy-induced senescent melanoma cells, but the cited melanoma study does not establish that ABT-263 itself was the tested compound. The findings therefore inform research questions rather than clinical efficacy or universal senolytic use.
-
Cy5-UTP in RNA Research: Uses, Evidence and Limits
2026-10-04
Cy5-UTP enables conceptual fluorescence-based RNA detection and probe design, but its strongest support in the supplied material is a commercial product description rather than independent validation. This overview compares its proposed uses in RNA probe synthesis, FISH and dual-color expression arrays with published findings on self-amplifying RNA lipid nanoparticles, clarifying what the evidence supports and where applicability ends.
-
ARCA Cy3 EGFP mRNA (5-moUTP): Reading Delivery Evidence
2026-10-03
ARCA Cy3 EGFP mRNA (5-moUTP) can help researchers distinguish where an mRNA goes from whether it produces protein. This article presents an evidence-centered framework linking fluorescent tracking, 5-methoxyuridine modified mRNA, and endosomal escape research without overstating what any single readout proves.
-
Seeing mRNA Work: From Uptake to Translation
2026-10-02
A mechanistic and translational framework for using fluorescent, modified reporter mRNA to distinguish delivery, intracellular trafficking, endosomal escape, and productive protein expression.
-
Berberine Hydrochloride: Mechanisms & Research Use
2026-10-01
Berberine hydrochloride is an isoquinoline alkaloid used in metabolic disease research, lipid metabolism modulation, and cancer biology. Its best-established research rationale centers on AMPK activation, LDL receptor regulation, and model-specific effects on apoptosis and ferroptosis.
-
Endothelial STING–JAK1 Signaling in Tumor Immunity
2026-10-01
The reference study identifies endothelial STING as an active regulator of tumor-vessel normalization and CD8+ T-cell infiltration, rather than merely an upstream adaptor for canonical interferon production. Its mechanistic finding that interferon signaling engages a palmitoylation-dependent STING–JAK1 interaction provides a framework for interpreting vascular immunotherapy responses and designing more discriminating endothelial assays.
-
NSC 87877: Practical Shp2 Inhibition Guide
2026-09-30
This bench-focused guide explains how NSC 87877, SKU A4544, can support Shp2 pathway, viability, proliferation, and cytotoxicity experiments. It connects biochemical potency, solvent compatibility, controls, and interpretation with recent SHP2-related neuroinflammation findings.
-
Isoprinosine Workflows for Antiviral Research
2026-09-30
Build reproducible Isoprinosine assays that separate direct viral effects from immune-cell modulation and cytotoxicity. The workflow connects HHV-1 replication studies with emerging herpesvirus nuclear-egress biology while defining practical controls, dosing ranges, and troubleshooting checkpoints.